[{"address1": "455 North Bernardo Avenue", "city": "Mountain View", "state": "CA", "zip": "94043", "country": "United States", "phone": "650 237 2700", "fax": "650 237 2701", "website": "https://www.neuropace.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.", "fullTimeEmployees": 184, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joel D. Becker", "age": 55, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 761996, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rebecca L. Kuhn", "age": 62, "title": "CFO, VP of Finance & Administration", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 614911, "exercisedValue": 0, "unexercisedValue": 1878733}, {"maxAge": 1, "name": "Dr. Martha J. Morrell M.D.", "age": 66, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 728676, "exercisedValue": 0, "unexercisedValue": 2921876}, {"maxAge": 1, "name": "Mr. Dylan  St. John", "title": "Chief of Operations & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah  Akin", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelley  Nicholas", "title": "Vice President of Sales", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy  Treadwell", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1733011200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 11.14, "open": 11.0, "dayLow": 10.76, "dayHigh": 11.55, "regularMarketPreviousClose": 11.14, "regularMarketOpen": 11.0, "regularMarketDayLow": 10.76, "regularMarketDayHigh": 11.55, "beta": 1.798, "forwardPE": -12.807126, "volume": 164399, "regularMarketVolume": 164399, "averageVolume": 82060, "averageVolume10days": 84470, "averageDailyVolume10Day": 84470, "bid": 11.2, "ask": 11.77, "bidSize": 600, "askSize": 100, "marketCap": 344148576, "fiftyTwoWeekLow": 5.45, "fiftyTwoWeekHigh": 18.15, "priceToSalesTrailing12Months": 4.5014987, "fiftyDayAverage": 8.736, "twoHundredDayAverage": 8.97885, "currency": "USD", "enterpriseValue": 360817600, "profitMargins": -0.36743, "floatShares": 11209454, "sharesOutstanding": 29848100, "sharesShort": 249421, "sharesShortPriorMonth": 437934, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.0084, "heldPercentInsiders": 0.040999997, "heldPercentInstitutions": 0.82875997, "shortRatio": 2.85, "shortPercentOfFloat": 0.017, "impliedSharesOutstanding": 29848100, "bookValue": 0.33, "priceToBook": 34.939392, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -28091000, "trailingEps": -0.98, "forwardEps": -1.05, "enterpriseToRevenue": 4.72, "enterpriseToEbitda": -15.777, "52WeekChange": 0.1646465, "SandP52WeekChange": 0.2421279, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NPCE", "underlyingSymbol": "NPCE", "shortName": "Neuropace, Inc.", "longName": "NeuroPace, Inc.", "firstTradeDateEpochUtc": 1619098200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f13ab7aa-24cb-3a1c-ae1c-2207cb9a0e40", "messageBoardId": "finmb_125322", "gmtOffSetMilliseconds": -18000000, "currentPrice": 11.53, "targetHighPrice": 20.0, "targetLowPrice": 13.0, "targetMeanPrice": 16.16667, "targetMedianPrice": 16.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 56830000, "totalCashPerShare": 1.904, "ebitda": -22870000, "totalDebt": 73499000, "quickRatio": 4.627, "currentRatio": 5.588, "totalRevenue": 76452000, "debtToEquity": 748.234, "revenuePerShare": 2.697, "returnOnAssets": -0.14741999, "returnOnEquity": -2.1455, "freeCashflow": -9622375, "operatingCashflow": -16493000, "revenueGrowth": 0.282, "grossMargins": 0.73827004, "ebitdaMargins": -0.29914, "operatingMargins": -0.20146999, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-21"}]